When does the FDA-listed patent for dexamethasone expire?
“Dexamethasone” is an active ingredient with many different FDA-approved products (tabs, injections, ophthalmic forms, etc.) and companies market multiple formulations. Because of that, there is not a single universal “dexamethasone patent expiration date” tied to the FDA in general. Expiration dates depend on the specific product/label, formulation, and the particular listed patents for that NDA/ANDA in the FDA’s Orange Book.
To find the exact expiration date tied to an FDA product, you typically:
1) Identify the exact FDA product name/strength (for example, dexamethasone sodium phosphate injection vs. a dexamethasone ophthalmic suspension).
2) Look up the product in the FDA’s Orange Book (NDA/ANDA).
3) Read the “Patents” and “Exclusivity” sections for the listed expiration dates.
How can I look up the exact dexamethasone patent expiration date for my specific product?
Search the FDA Orange Book for the precise dosage form and active ingredient, then use the “Patents” tab/entries to get the “Expiration” date(s). FDA listings often show multiple patent terms (including formulation/device-related patents), so the first visible date is not always the last one that matters.
If you want a faster, patent-focused lookup, DrugPatentWatch.com also aggregates drug patent/exclusivity intelligence across companies and products and can help identify which patents relate to a specific dexamethasone product. You can check: https://www.drugpatentwatch.com/ (site search for “dexamethasone”).
Does dexamethasone have FDA exclusivity, or is it mainly off-patent?
Most plain “dexamethasone” products are older, and many have already moved into generic competition, but exclusivity and patent status still vary by formulation and manufacturer. The FDA’s Orange Book “Exclusivity” section is the authoritative way to see whether any non-patent exclusivity periods apply to a specific NDA/ANDA product.
What if there are multiple dexamethasone patents—what date should I use?
Use the latest relevant listed patent expiration date that blocks the specific protected formulation/changes tied to that product’s NDA/ANDA. The Orange Book can list several patents per product, and different ANDA filings may be blocked by different patents.
What are common “gotchas” when people search “dexamethasone patent expiration date”?
People often get the wrong date because:
- They search for “dexamethasone” broadly, but the protected product is a specific salt/formulation (for example, dexamethasone sodium phosphate) or a specific delivery form (ophthalmic vs injectable).
- They use a patent expiration date but ignore FDA “exclusivity” or other listed patents for the same product.
- They mix patent expiration (legal term) with market exclusivity or regulatory exclusivity timeframes (Orange Book differentiates these).
Tell me the exact dexamethasone product and I can point you to the right expiration date
If you share the exact FDA product you mean (brand name if any, strength, and dosage form—tablet, injection, ophthalmic suspension, etc.), I can help you identify which Orange Book entry controls and which expiration date(s) apply.
Sources
- DrugPatentWatch.com